During the past decade, Klinikiniai sprendimai, UAB conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikiniai sprendimai, UAB" are "Atherosclerotic Cardiovascular Disease" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Klinikiniai sprendimai, UAB" in a lesser frequency.

Most popular intervention types in "Klinikiniai sprendimai, UAB" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikiniai sprendimai, UAB" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikiniai sprendimai, UAB". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinikiniai sprendimai, UAB, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikiniai sprendimai, UAB, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".